Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion

JW Hart, LH Shiue, EJ Shpall… - Therapeutic advances …, 2013 - journals.sagepub.com
Despite significant advances in prevention and treatment strategies, graft-versus-host
disease remains the most significant cause of morbidity and nonrelapse mortality after …

Extracorporeal photopheresis for treatment of acute and chronic graft versus host disease: an Italian multicentric retrospective analysis on 94 patients on behalf of the …

M Malagola, V Cancelli, C Skert, PF Leali… - …, 2016 - journals.lww.com
Background Extracorporeal photopheresis (ECP) is considered a valid second-line
treatment for acute and chronic graft versus host disease (GVHD). Methods Ninety-four …

Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from …

Ø Bruserud, THA Tvedt, PQ Paulsen, AB Ahmed… - Cancer Immunology …, 2014 - Springer
Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - frontiersin.org
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Efficacy and safety of one‐day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft‐versus‐host disease

J Cid, G Carbassé, M Suárez‐Lledó, DF Moreno… - …, 2019 - Wiley Online Library
BACKGROUND Extracorporeal photopheresis (ECP) has been increasingly used as a
second‐line therapy for graft‐versus‐host disease (GVHD) but there is no consensus …

National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis

N Ratcliffe, NM Dunbar, J Adamski, D Couriel… - Transfusion medicine …, 2015 - Elsevier
The clinical use of extracorporeal photopheresis (ECP) for accepted indications such as
graft-versus-host disease, transplant rejection, and cutaneous T-cell lymphoma continues to …

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults

S Bos, J Murray, M Marchetti, GS Cheng… - European …, 2024 - Eur Respiratory Soc
Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic
haematopoietic stem cell transplantation, characterised by a broad disease spectrum that …

The role of extracorporeal photopheresis in chronic graft-versus-host disease

V Radojcic, MA Pletneva, DR Couriel - Transfusion and Apheresis Science, 2015 - Elsevier
Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …